Replies to post #311358 on Anavex Life Sciences Corp (AVXL)

[bas2020]

True... and the sites will continue to over enroll some %.

[imho]

Regarding drug trial recruitment...

One item people need to be aware of is that patient enrollment is deliberately spread across multiple sites without having any one site having a preponderance of patients in the trial. In order to avoid any bias by site or investigator trials will proportion approximately how many patients are required at each site.

A trial targeting 450 patients across 30 sites and 98% enrolled might seem like it should only take another week to be fully enrolled. The reality is that the last couple of sites that opened for recruitment will need to be the sites that fill the last spots. This could take several weeks or a month.

All of what you say, if true, could be easily communicated by a well compensated CEO. That is not what is happening.

IMHO